Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

SELL
$211.93 - $241.33 $21,193 - $24,133
-100 Reduced 4.08%
2,350 $567,000
Q3 2021

Oct 22, 2021

SELL
$274.82 - $308.34 $178,633 - $200,420
-650 Reduced 20.97%
2,450 $690,000
Q2 2021

Aug 02, 2021

SELL
$251.87 - $278.14 $623,378 - $688,396
-2,475 Reduced 44.39%
3,100 $855,000
Q3 2020

Oct 06, 2020

SELL
$167.03 - $201.3 $33,406 - $40,260
-200 Reduced 3.46%
5,575 $1.05 Million
Q2 2020

Jul 16, 2020

SELL
$113.31 - $182.44 $22,662 - $36,488
-200 Reduced 3.35%
5,775 $959,000
Q3 2019

Oct 17, 2019

SELL
$159.77 - $178.1 $59,913 - $66,787
-375 Reduced 5.91%
5,975 $1 Million
Q4 2018

Feb 04, 2019

SELL
$120.82 - $174.09 $84,574 - $121,863
-700 Reduced 9.93%
6,350 $802,000
Q2 2018

Oct 05, 2018

SELL
$160.33 - $189.41 $32,066 - $37,882
-200 Reduced 2.76%
7,050 $1.27 Million
Q2 2017

Aug 14, 2017

BUY
N/A
7,250
7,250 $1.12 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Optimum Investment Advisors Portfolio

Follow Optimum Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.